CRYM (CRYM) Stock Price & Analysis
CRYM (CRYM) rose 0.00% to USD 0 as of June 10, 2026 at 14:40 UTC, according to Nexqual real-time market data.
CRYM last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 15,950 shares. Market capitalization is $47,431, with a 52-week range of USD 0–0.03 (PNK). Source: Nexqual, June 10, 2026 at 14:40 UTC.
Key Statistics (as of June 10, 2026 at 14:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.03 |
| Volume | 15,950 shares |
| Market Cap | $47,431 |
| Exchange | PNK |
Technical Analysis (CRYM)
Nexqual's technical model rates CRYM "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 14:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CRYM)
Wall Street analysts rate CRYM "None", per Nexqual as of June 10, 2026 at 14:40 UTC.
| Consensus Rating | None |
|---|
Earnings (CRYM)
Source: Nexqual, June 10, 2026 at 14:40 UTC.
Financials & Fundamentals (CRYM)
| Total Revenue | $37,741 |
|---|---|
| Gross Margin | +100.00% |
| Operating Margin | -17317.18% |
| Profit Margin | +0.00% |
| Current Ratio | 0.04 |
| Total Cash | $183,439 |
| Total Debt | $6.00M |
| Free Cash Flow | $512,032 |
Source: Nexqual, June 10, 2026 at 14:40 UTC.
Financial Health Score (CRYM)
Nexqual rates CRYM's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 14:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $183K cash vs $6M debt |
| Cash Flow | Strong — FCF $512K, 1357% margin |
| Efficiency | Mixed — No data |
Ownership (CRYM)
| Insider Ownership | +15.72% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 237.16M |
| Float | 228.62M |
Source: Nexqual, June 10, 2026 at 14:40 UTC.
Leadership (CRYM)
CRYM is led by Christian Noel (age 48), CEO & Director, per Nexqual as of June 10, 2026 at 14:40 UTC.
| CEO & Director | Christian Noel (age 48) |
|---|---|
| Chief Financial Officer | Philip Blair Mullin B.A. (age 71) |
| Chief Operating Officer of Good Meds | Ryan Smith |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NSCI.V | NANALYSIS SCIENTIFIC CORP | CAD 0.13 | ▲ 0% |
| BBBT | BLACK BIRD BIOTECH INC | USD 0 | ▲ 0% |
| SNRG | Susglobal Energy Corp. | USD 0.02 | ▼ 2.08% |
| HYEX | HEALTHY EXTRACTS INC. | USD 2.7 | ▲ 1.51% |
| VSOLF | THREE SIXTY SOLAR LTD. | USD 0.01 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 14:40 UTC. This page is informational and not investment advice.